• Biopharma companies face regulatory, deal delays due to Covid-19

    9 days ago - By MedCity News

    Intercept Pharmaceuticals and bluebird bio said they had encountered regulatory snags at the FDA for their investigational drugs, while Pfizer is pausing most of its clinical trials and delaying completion of a deal with Mylan to create a new company.
    Read more ...

     

  • PRA expands app for conducting clinical trials remotely during Covid-19 pandemic

    PRA expands app for conducting clinical trials remotely during Covid-19 pandemic

    9 days ago - By MedCity News

    The contract research organization's announcement came as clinical trial sites anticipate significant disruption due to the pandemic, while the FDA has issued guidelines for running trials virtually.
    Read more ...